Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies-Reference-Cited by-同舟云学术

Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies

Published:2016-10 Issue:5 Volume:16 Page:327-334
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Petrelli Fausto,Di Cosimo Serena,Lonati Veronica,Barni Sandro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer;Piccart-Gebhart;J Clin Oncol,2008

2. The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review;Jassem;Eur J Cancer,2009

3. Capecitabine and vinorelbine in metastatic breast cancer;Chan;Eur J Cancer,2009

4. Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer;Nolè;Cancer Chemother Pharmacol,2009

5. All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an international phase II trial;Tubiana-Mathieu;Br J Cancer,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer;Cancer Medicine;2024-04

2. Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review;Breast Cancer: Targets and Therapy;2024-04

3. Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial;European Journal of Cancer;2024-01

4. A review of FDA approved drugs and their formulations for the treatment of breast cancer;Frontiers in Pharmacology;2023-07-28

5. A Complete Response of Orbital Metastases in Breast Cancer Patient Treated with Oral Chemotherapy: Case Report and Literature Review;Case Reports in Oncology;2022-04-21